Thompson Investment Management Inc. Sells 244 Shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC)

Thompson Investment Management Inc. trimmed its position in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 0.5% during the 4th quarter, Holdings Channel.com reports. The institutional investor owned 49,811 shares of the company’s stock after selling 244 shares during the quarter. Thompson Investment Management Inc.’s holdings in GE HealthCare Technologies were worth $3,894,000 at the end of the most recent reporting period.

Several other large investors have also recently added to or reduced their stakes in GEHC. Park Avenue Securities LLC grew its stake in shares of GE HealthCare Technologies by 38.8% during the third quarter. Park Avenue Securities LLC now owns 4,058 shares of the company’s stock valued at $381,000 after purchasing an additional 1,135 shares during the last quarter. CWM LLC grew its stake in GE HealthCare Technologies by 5.0% in the 3rd quarter. CWM LLC now owns 11,186 shares of the company’s stock valued at $1,050,000 after buying an additional 531 shares during the last quarter. Wedmont Private Capital boosted its holdings in GE HealthCare Technologies by 16.2% in the 3rd quarter. Wedmont Private Capital now owns 5,584 shares of the company’s stock valued at $503,000 after purchasing an additional 777 shares during the period. UMB Bank n.a. lifted its holdings in shares of GE HealthCare Technologies by 34.2% during the 3rd quarter. UMB Bank n.a. now owns 2,058 shares of the company’s stock worth $193,000 after acquiring an additional 524 shares during the period. Finally, Clarius Group LLC acquired a new position in GE HealthCare Technologies during the 3rd quarter worth approximately $229,000. 82.06% of the stock is owned by institutional investors.

GE HealthCare Technologies Price Performance

GEHC opened at $87.64 on Friday. The firm has a 50-day moving average price of $83.34 and a 200-day moving average price of $85.25. The company has a quick ratio of 0.98, a current ratio of 1.23 and a debt-to-equity ratio of 1.12. GE HealthCare Technologies Inc. has a twelve month low of $74.51 and a twelve month high of $94.55. The company has a market capitalization of $40.04 billion, a price-to-earnings ratio of 24.08, a PEG ratio of 2.93 and a beta of 1.15.

GE HealthCare Technologies Increases Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, February 14th. Stockholders of record on Tuesday, January 14th will be given a $0.035 dividend. This is a positive change from GE HealthCare Technologies’s previous quarterly dividend of $0.03. This represents a $0.14 dividend on an annualized basis and a dividend yield of 0.16%. The ex-dividend date of this dividend is Tuesday, January 14th. GE HealthCare Technologies’s dividend payout ratio (DPR) is 3.85%.

Analyst Upgrades and Downgrades

Several equities research analysts have recently weighed in on the stock. Jefferies Financial Group upgraded shares of GE HealthCare Technologies from a “hold” rating to a “buy” rating and increased their price objective for the stock from $95.00 to $103.00 in a research report on Wednesday, January 8th. Wells Fargo & Company increased their target price on shares of GE HealthCare Technologies from $95.00 to $96.00 and gave the stock an “overweight” rating in a research note on Thursday, October 31st. One investment analyst has rated the stock with a sell rating, four have given a hold rating, nine have given a buy rating and one has given a strong buy rating to the company. According to data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average target price of $96.00.

About GE HealthCare Technologies

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.